rop phlebotomy classes phlebotomy training courses phlebotomy training riverside ca
Thursday, 15 August 2013
Drug developed by UCSF researcher strikingly effective in type 1 diabetes clinical trial
An experimental drug designed to block the advance of type 1 diabetes in its earliest stages has proven strikingly effective over two years in about half of the patients who participated in the phase 2 clinical trial. Patients who benefited most were those who still had relatively good control of their blood sugar levels and only a moderate need for insulin injections when the trial began. With the experimental drug, teplizumab, they were able to maintain their level of insulin production for the full two years -- longer than with most other drugs tested against the disease... (Source: Health News from Medical News Today)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment